{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T18:10:31Z","timestamp":1769278231058,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,11,3]],"date-time":"2017-11-03T00:00:00Z","timestamp":1509667200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s00125-017-4485-y","type":"journal-article","created":{"date-parts":[[2017,11,3]],"date-time":"2017-11-03T00:49:17Z","timestamp":1509670157000},"page":"581-588","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Three-question set from Michigan Neuropathy Screening Instrument adds independent prognostic information on cardiovascular outcomes: analysis of ALTITUDE trial"],"prefix":"10.1007","volume":"61","author":[{"given":"Jelena P.","family":"Seferovic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc A.","family":"Pfeffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Claggett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akshay S.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dick","family":"de Zeeuw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven M.","family":"Haffner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John J. V.","family":"McMurray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Henrik","family":"Parving","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott D.","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nish","family":"Chaturvedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,3]]},"reference":[{"key":"4485_CR1","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1007\/s001250051062","volume":"41","author":"CM Forsblom","year":"1998","unstructured":"Forsblom CM, Sane T, Groop PH et al (1998) Risk factors for mortality in type II (non-insulin-dependent) diabetes: evidence of a role for neuropathy and a protective effect of HLA-DR4. Diabetologia 41:1253\u20131262","journal-title":"Diabetologia"},{"key":"4485_CR2","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.2337\/dc08-0107","volume":"31","author":"SS Soedamah-Muthu","year":"2008","unstructured":"Soedamah-Muthu SS, Chaturvedi N, Witte DR et al (2008) Relationship between risk factors and mortality in type 1 diabetic patients in Europe: the EURODIAB prospective complications study. Diabetes Care 31:1360\u20131366","journal-title":"Diabetes Care"},{"key":"4485_CR3","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S0895-4356(99)00170-5","volume":"53","author":"DV Coppini","year":"2000","unstructured":"Coppini DV, Bowtell PA, Weng C, Young PJ, S\u00f6nksen PH (2000) Showing neuropathy is related to increased mortality in diabetic patients\u2014a survival analysis using an accelerated failure time model. J Clin Epidemiol 53:519\u2013523","journal-title":"J Clin Epidemiol"},{"key":"4485_CR4","first-page":"1","volume":"1","author":"L Ang","year":"2014","unstructured":"Ang L, Jaiswal M, Martin C, Pop-Busui R (2014) Glucose control and diabetic neuropathy: lessons from recent large clinical trials. Curr Diab Rep 1:1\u201315","journal-title":"Curr Diab Rep"},{"key":"4485_CR5","doi-asserted-by":"crossref","unstructured":"Tesfaye S, Chaturvedi N, Eaton SE, et al. EURODIAB Prospective Complications Study Group (2005) Vascular risk factors and diabetic neuropathy. N Engl J Med 352:341\u2013350","DOI":"10.1056\/NEJMoa032782"},{"key":"4485_CR6","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.2337\/dc10-1303","volume":"33","author":"S Tesfaye","year":"2010","unstructured":"Tesfaye S, Boulton AJ, Dyck PJ et al (2010) Toronto Diabetic Neuropathy Expert Group. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 33:2285\u20132293","journal-title":"Diabetes Care"},{"key":"4485_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2008.05.005","volume":"120","author":"JL Edwards","year":"2008","unstructured":"Edwards JL, Vincent AM, Cheng HT, Feldman EL (2008) Diabetic neuropathy: mechanisms to management. Pharmacol Ther 120:1\u201334","journal-title":"Pharmacol Ther"},{"key":"4485_CR8","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.2337\/diacare.17.11.1281","volume":"17","author":"EL Feldman","year":"1994","unstructured":"Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA (1994) A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 17:1281\u20131289","journal-title":"Diabetes Care"},{"key":"4485_CR9","doi-asserted-by":"crossref","unstructured":"Pop-Busui R, Evans GW, Gerstein HC, et al. Action to Control Cardiovascular Risk in Diabetes Study Group (2010) Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diabetes Care 33:1688\u20131690","DOI":"10.2337\/dc10-0125"},{"key":"4485_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1529-8027.2009.00200.x","volume":"14","author":"R Pop-Busui","year":"2009","unstructured":"Pop-Busui R, Lu J, Lopes N, Jones TL, BARI 2D Investigators (2009) Prevalence of diabetic peripheral neuropathy and relation to glycemic control therapies at baseline in the BARI 2D cohort. J Peripher Nerv Syst 14:1\u201313","journal-title":"J Peripher Nerv Syst"},{"key":"4485_CR11","doi-asserted-by":"crossref","unstructured":"Herman WH, Pop-Busui R, Braffett BH, et al. DCCT\/EDIC Research Group (2012) Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in type 1 diabetes: results from the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications. Diabet Med 29:937\u2013944","DOI":"10.1111\/j.1464-5491.2012.03644.x"},{"key":"4485_CR12","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1093\/ndt\/gfn721","volume":"24","author":"HH Parving","year":"2009","unstructured":"Parving HH, Brenner BM, McMurray JJ et al (2009) Aliskiren trial in type 2 diabetes using cardio-renal endpoints (ALTITUDE): rationale and study design. Nephrol Dial Transplant 24:1663\u20131671","journal-title":"Nephrol Dial Transplant"},{"key":"4485_CR13","doi-asserted-by":"crossref","unstructured":"Parving HH, Brenner BM, McMurray JJ, et al. ALTITUDE Investigators (2012) Cardiorenal end points in a trial of aliskiren for type 2 diabetes. N Engl J Med 367: 2204\u20132213","DOI":"10.1056\/NEJMoa1208799"},{"key":"4485_CR14","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1093\/eurheartj\/ehv295","volume":"36","author":"PS Jhund","year":"2015","unstructured":"Jhund PS, McMurray JJ, Chaturvedi N et al (2015) Mortality following a cardiovascular or renal event in patients with type 2 diabetes in the ALTITUDE trial. Eur Heart J 36:2463\u20132469","journal-title":"Eur Heart J"},{"key":"4485_CR15","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1177\/1536867X1001000303","volume":"10","author":"RB Newson","year":"2010","unstructured":"Newson RB (2010) Comparing the predictive powers of survival models using Harrell\u2019s C or Somers\u2019 D. Stata J 10:339","journal-title":"Stata J"},{"key":"4485_CR16","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1161\/01.HYP.0000216717.72048.6c","volume":"47","author":"N Witt","year":"2006","unstructured":"Witt N, Wong TY, Hughes AD et al (2006) Abnormalities of retinal microvascular structure and risk of mortality from ischemic heart disease and stroke. Hypertension 47:975\u2013981","journal-title":"Hypertension"},{"key":"4485_CR17","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s00125-015-3511-1","volume":"58","author":"CY Cheung","year":"2015","unstructured":"Cheung CY, Ikram MK, Klein R, Wong TY (2015) The clinical implications of recent studies on the structure and function of the retinal microvasculature in diabetes. Diabetologia 58:871\u2013885","journal-title":"Diabetologia"},{"key":"4485_CR18","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5","volume":"19","author":"DG Altman","year":"2000","unstructured":"Altman DG, Royston P (2000) What do we mean by validating a prognostic model? Stat Med 19:453\u2013473","journal-title":"Stat Med"},{"key":"4485_CR19","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1136\/heartjnl-2011-301247","volume":"98","author":"KG Moons","year":"2012","unstructured":"Moons KG, Kengne AP, Grobbee DE et al (2012) Risk prediction models: II. External validation, model updating, and impact assessment. Heart 98:691\u2013698","journal-title":"Heart"},{"key":"4485_CR20","doi-asserted-by":"publisher","first-page":"b605","DOI":"10.1136\/bmj.b605","volume":"338","author":"DG Altman","year":"2009","unstructured":"Altman DG, Vergouwe Y, Royston P, Moons KG (2009) Prognosis and prognostic research: validating a prognostic model. BMJ 338:b605","journal-title":"BMJ"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-017-4485-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-017-4485-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-017-4485-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T14:20:20Z","timestamp":1570285220000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-017-4485-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,3]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["4485"],"URL":"https:\/\/doi.org\/10.1007\/s00125-017-4485-y","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,3]]}}}